Search Results

You are looking at 91 - 100 of 1,605 items for :

  • breast cancer x
  • Refine by access: All content x
Clear All
Maria Wielsøe Centre for Arctic Health & Molecular Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark

Search for other papers by Maria Wielsøe in
Google Scholar
PubMed
Close
,
Christian Bjerregaard-Olesen Centre for Arctic Health & Molecular Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark

Search for other papers by Christian Bjerregaard-Olesen in
Google Scholar
PubMed
Close
,
Peder Kern Department of Gynecology and Obstetrics, Dronning Ingrid’s Hospital, Nuuk, Greenland

Search for other papers by Peder Kern in
Google Scholar
PubMed
Close
, and
Eva Cecilie Bonefeld-Jørgensen Centre for Arctic Health & Molecular Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark
Institute for Nursing and Health Science, University of Greenland, Nuuk, Greenland

Search for other papers by Eva Cecilie Bonefeld-Jørgensen in
Google Scholar
PubMed
Close

Introduction Breast cancer is the most common cancer among women, and tumor growth is often hormone dependent ( Ferlay et al . 2015 ). Estrogen receptors (ER) and progesterone receptor are expressed in up to 75% of all breast cancer tumors

Free access
Xiao-Dong Fu Molecular and Cellular Gynecological Endocrinology Laboratory (MCGEL), Department of Physiology, Department of Reproductive Medicine and Child Development, University of Pisa, Pisa 56100, Italy
Molecular and Cellular Gynecological Endocrinology Laboratory (MCGEL), Department of Physiology, Department of Reproductive Medicine and Child Development, University of Pisa, Pisa 56100, Italy

Search for other papers by Xiao-Dong Fu in
Google Scholar
PubMed
Close
,
Lorenzo Goglia Molecular and Cellular Gynecological Endocrinology Laboratory (MCGEL), Department of Physiology, Department of Reproductive Medicine and Child Development, University of Pisa, Pisa 56100, Italy

Search for other papers by Lorenzo Goglia in
Google Scholar
PubMed
Close
,
Angel Matias Sanchez Molecular and Cellular Gynecological Endocrinology Laboratory (MCGEL), Department of Physiology, Department of Reproductive Medicine and Child Development, University of Pisa, Pisa 56100, Italy

Search for other papers by Angel Matias Sanchez in
Google Scholar
PubMed
Close
,
Marina Flamini Molecular and Cellular Gynecological Endocrinology Laboratory (MCGEL), Department of Physiology, Department of Reproductive Medicine and Child Development, University of Pisa, Pisa 56100, Italy

Search for other papers by Marina Flamini in
Google Scholar
PubMed
Close
,
Maria S Giretti Molecular and Cellular Gynecological Endocrinology Laboratory (MCGEL), Department of Physiology, Department of Reproductive Medicine and Child Development, University of Pisa, Pisa 56100, Italy

Search for other papers by Maria S Giretti in
Google Scholar
PubMed
Close
,
Veronica Tosi Molecular and Cellular Gynecological Endocrinology Laboratory (MCGEL), Department of Physiology, Department of Reproductive Medicine and Child Development, University of Pisa, Pisa 56100, Italy

Search for other papers by Veronica Tosi in
Google Scholar
PubMed
Close
,
Andrea R Genazzani Molecular and Cellular Gynecological Endocrinology Laboratory (MCGEL), Department of Physiology, Department of Reproductive Medicine and Child Development, University of Pisa, Pisa 56100, Italy

Search for other papers by Andrea R Genazzani in
Google Scholar
PubMed
Close
, and
Tommaso Simoncini Molecular and Cellular Gynecological Endocrinology Laboratory (MCGEL), Department of Physiology, Department of Reproductive Medicine and Child Development, University of Pisa, Pisa 56100, Italy

Search for other papers by Tommaso Simoncini in
Google Scholar
PubMed
Close

Introduction Progesterone is a major regulator of breast epithelial cell proliferation and differentiation; however, the connection between this hormone and breast cancer is still a matter of debate ( Yager & Davidson 2006 , Hankinson & Eliassen

Free access
Vasily N Aushev Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, New York, USA

Search for other papers by Vasily N Aushev in
Google Scholar
PubMed
Close
,
Kalpana Gopalakrishnan Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, New York, USA

Search for other papers by Kalpana Gopalakrishnan in
Google Scholar
PubMed
Close
,
Susan L Teitelbaum Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, New York, USA

Search for other papers by Susan L Teitelbaum in
Google Scholar
PubMed
Close
,
Humberto Parada Jr Division of Epidemiology & Biostatistics, School of Public Health, San Diego State University, San Diego, California, USA

Search for other papers by Humberto Parada Jr in
Google Scholar
PubMed
Close
,
Regina M Santella Department of Environmental Health Sciences, Columbia University, New York, New York, USA

Search for other papers by Regina M Santella in
Google Scholar
PubMed
Close
,
Marilie D Gammon University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA

Search for other papers by Marilie D Gammon in
Google Scholar
PubMed
Close
, and
Jia Chen Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA

Search for other papers by Jia Chen in
Google Scholar
PubMed
Close

progression of breast cancer ( Darbre & Harvey 2014 , Giulivo et al. 2016 , Benjamin et al. 2017 ), but existing data on this subject are scarce, especially for humans. Our study focuses on two specific phthalate and paraben congeners: diethyl

Restricted access
Tanya K Day
Search for other papers by Tanya K Day in
Google Scholar
PubMed
Close
and
Tina Bianco-Miotto Dame Roma Mitchell Cancer Research Laboratories, School of Paediatrics and Reproductive Health, School of Agriculture, Discipline of Medicine, Hanson Institute, Adelaide Prostate Cancer Research Centre, The University of Adelaide, Adelaide, South Australia, Australia
Dame Roma Mitchell Cancer Research Laboratories, School of Paediatrics and Reproductive Health, School of Agriculture, Discipline of Medicine, Hanson Institute, Adelaide Prostate Cancer Research Centre, The University of Adelaide, Adelaide, South Australia, Australia

Search for other papers by Tina Bianco-Miotto in
Google Scholar
PubMed
Close

Introduction Numerous diseases are associated with abnormal hormonal regulation including breast and prostate cancers. Breast cancer is a heterogeneous disease that can be classified in many ways. The most primary classification is by hormone

Free access
T Kogai
Search for other papers by T Kogai in
Google Scholar
PubMed
Close
,
K Taki
Search for other papers by K Taki in
Google Scholar
PubMed
Close
, and
G A Brent
Search for other papers by G A Brent in
Google Scholar
PubMed
Close

concentrate iodide to a similar degree as that seen in the thyroid, producing milk with an iodine concentration of 20–700 μg/l ( Simon et al. 2002 b ). NIS expression has been demonstrated in more than 80% breast cancer tissue, although the fraction of

Free access
Alyson Murray UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland

Search for other papers by Alyson Murray in
Google Scholar
PubMed
Close
,
Stephen F Madden Division of Population Health Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland

Search for other papers by Stephen F Madden in
Google Scholar
PubMed
Close
,
Naoise C Synnott UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland

Search for other papers by Naoise C Synnott in
Google Scholar
PubMed
Close
,
Rut Klinger UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland

Search for other papers by Rut Klinger in
Google Scholar
PubMed
Close
,
Darran O'Connor Department of Molecular & Cellular Therapeutics, Royal College of Surgeons Ireland, Dublin, Ireland

Search for other papers by Darran O'Connor in
Google Scholar
PubMed
Close
,
Norma O'Donovan National Institute for Cellular Biotechnology (NICB), Dublin City University, Dublin, Ireland

Search for other papers by Norma O'Donovan in
Google Scholar
PubMed
Close
,
William Gallagher UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland

Search for other papers by William Gallagher in
Google Scholar
PubMed
Close
,
John Crown Department of Medical Oncology, St. Vincent’s University Hospital, Dublin, Ireland

Search for other papers by John Crown in
Google Scholar
PubMed
Close
, and
Michael J Duffy UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland
UCD Clinical Research Centre, St. Vincent’s University Hospital, Dublin, Ireland

Search for other papers by Michael J Duffy in
Google Scholar
PubMed
Close

have been widely exploited as therapeutic targets in cancer (i.e., ER in breast cancer ( EBCTCG et al. 2011 ) and AR in prostate cancer ( Valenca et al. 2015 )), less work has been carried out on targeting VDR. There are, however, several

Free access
Adena E Rosenblatt
Search for other papers by Adena E Rosenblatt in
Google Scholar
PubMed
Close
,
Maria Ines Garcia
Search for other papers by Maria Ines Garcia in
Google Scholar
PubMed
Close
,
Leah Lyons Department of Molecular and Cellular Pharmacology, Nova Southeastern University, Department of Medicine, ExonHit Therapeutics, University of Miami Miller School of Medicine, 1600 Northwest 10th Avenue (R-189), Miami, Florida 33136, USA

Search for other papers by Leah Lyons in
Google Scholar
PubMed
Close
,
Yingqiu Xie Department of Molecular and Cellular Pharmacology, Nova Southeastern University, Department of Medicine, ExonHit Therapeutics, University of Miami Miller School of Medicine, 1600 Northwest 10th Avenue (R-189), Miami, Florida 33136, USA

Search for other papers by Yingqiu Xie in
Google Scholar
PubMed
Close
,
Carol Maiorino
Search for other papers by Carol Maiorino in
Google Scholar
PubMed
Close
,
Laurent Désiré Department of Molecular and Cellular Pharmacology, Nova Southeastern University, Department of Medicine, ExonHit Therapeutics, University of Miami Miller School of Medicine, 1600 Northwest 10th Avenue (R-189), Miami, Florida 33136, USA

Search for other papers by Laurent Désiré in
Google Scholar
PubMed
Close
,
Joyce Slingerland Department of Molecular and Cellular Pharmacology, Nova Southeastern University, Department of Medicine, ExonHit Therapeutics, University of Miami Miller School of Medicine, 1600 Northwest 10th Avenue (R-189), Miami, Florida 33136, USA

Search for other papers by Joyce Slingerland in
Google Scholar
PubMed
Close
, and
Kerry L Burnstein
Search for other papers by Kerry L Burnstein in
Google Scholar
PubMed
Close

implicated in breast cancer cell invasion and metastasis ( Fritz et al . 2002 , Burbelo et al . 2004 , Baugher et al . 2005 , Chan et al . 2005 , Xie & Haslam 2008 ). Furthermore, Rho GTPases may also function as mediators of epidermal growth factor

Free access
Aleksandra M Ochnik Kolling Institute of Medical Research, University of Sydney, Royal North Shore Hospital, St Leonards, New South Wales, Australia

Search for other papers by Aleksandra M Ochnik in
Google Scholar
PubMed
Close
and
Robert C Baxter Kolling Institute of Medical Research, University of Sydney, Royal North Shore Hospital, St Leonards, New South Wales, Australia

Search for other papers by Robert C Baxter in
Google Scholar
PubMed
Close

, in the inhibition of the human epidermal growth factor (EGF) receptor-2 (HER2) in women with HER2-positive breast cancer and the blockade of EGF receptor kinase activity in non-small-cell lung cancer. In contrast, the insulin-like growth factor (IGF

Free access
L Zeng IGFs and Metabolic Endocrinology Group, Department of Clinical Oncology, School of Clinical Sciences, University of Bristol, Learning and Research Building, Southmead Hospital, Bristol BS10 1TD, UK

Search for other papers by L Zeng in
Google Scholar
PubMed
Close
,
H A Zielinska IGFs and Metabolic Endocrinology Group, Department of Clinical Oncology, School of Clinical Sciences, University of Bristol, Learning and Research Building, Southmead Hospital, Bristol BS10 1TD, UK

Search for other papers by H A Zielinska in
Google Scholar
PubMed
Close
,
A Arshad IGFs and Metabolic Endocrinology Group, Department of Clinical Oncology, School of Clinical Sciences, University of Bristol, Learning and Research Building, Southmead Hospital, Bristol BS10 1TD, UK

Search for other papers by A Arshad in
Google Scholar
PubMed
Close
,
J P Shield IGFs and Metabolic Endocrinology Group, Department of Clinical Oncology, School of Clinical Sciences, University of Bristol, Learning and Research Building, Southmead Hospital, Bristol BS10 1TD, UK

Search for other papers by J P Shield in
Google Scholar
PubMed
Close
,
A Bahl IGFs and Metabolic Endocrinology Group, Department of Clinical Oncology, School of Clinical Sciences, University of Bristol, Learning and Research Building, Southmead Hospital, Bristol BS10 1TD, UK

Search for other papers by A Bahl in
Google Scholar
PubMed
Close
,
J M P Holly IGFs and Metabolic Endocrinology Group, Department of Clinical Oncology, School of Clinical Sciences, University of Bristol, Learning and Research Building, Southmead Hospital, Bristol BS10 1TD, UK

Search for other papers by J M P Holly in
Google Scholar
PubMed
Close
, and
C M Perks IGFs and Metabolic Endocrinology Group, Department of Clinical Oncology, School of Clinical Sciences, University of Bristol, Learning and Research Building, Southmead Hospital, Bristol BS10 1TD, UK

Search for other papers by C M Perks in
Google Scholar
PubMed
Close

Introduction Breast cancer is the most common malignancy in women with a lifetime risk of one in eight. In all Western societies women present with breast cancer are increasingly likely to also suffer from co-morbid conditions such as diabetes and

Free access
Etienne Leygue Department of Biochemistry and Medical Genetics, Manitoba Institute of Cell Biology, University of Manitoba, 675 McDermot Avenue, Winnipeg, Manitoba, Canada R3E 0V9

Search for other papers by Etienne Leygue in
Google Scholar
PubMed
Close
and
Leigh C Murphy Department of Biochemistry and Medical Genetics, Manitoba Institute of Cell Biology, University of Manitoba, 675 McDermot Avenue, Winnipeg, Manitoba, Canada R3E 0V9

Search for other papers by Leigh C Murphy in
Google Scholar
PubMed
Close

Introduction The critical role of estrogen in human breast cancer is undisputed. The practical consequences of the concept of inhibiting the mitogenic action of estrogen on breast cancer cells have been the successful establishment of the endocrine

Free access